Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new deployment of the page. This update reflects an internal change to the page rather than a modification to the study details or user-facing content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor site update to the page. The change does not affect the study content or user interactions.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page’s revision tag changed from v3.6.2 to v3.6.3, signaling a minor platform/template update.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small update to the page or its template without changes to the study information.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page adds new user-guidance sections and reflects a recruitment status change, including No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and standardizes the Intervention/Treatment label. It also updates the page revision to v3.6.0 and removes the older Intervention / Treatment label and Revision: v3.5.5.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.